SLC10A2

Chr 13

solute carrier family 10 member 2

Also known as: ASBT, IBAT, ISBT, NTCP2, PBAM, PBAM1

This gene encodes a sodium/bile acid cotransporter. This transporter is the primary mechanism for uptake of intestinal bile acids by apical cells in the distal ileum. Bile acids are the catabolic product of cholesterol metabolism, so this protein is also critical for cholesterol homeostasis. Mutations in this gene cause primary bile acid malabsorption (PBAM); muatations in this gene may also be associated with other diseases of the liver and intestines, such as familial hypertriglyceridemia (FHTG). [provided by RefSeq, Mar 2010]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 1.94
Clinical SummarySLC10A2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 268 VUS of 419 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.94LOEUF
pLI 0.000
Z-score -2.02
OE 1.62 (1.111.94)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-2.20Z-score
OE missense 1.43 (1.301.58)
292 obs / 203.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.62 (1.111.94)
00.351.4
Missense OE?1.43 (1.301.58)
00.61.4
Synonymous OE?1.13
01.21.6
LoF obs/exp: 20 / 12.4Missense obs/exp: 292 / 203.5Syn Z: -0.98

This gene — mechanism propensity

DN
0.74top 25%
GOF
0.79top 25%
LOF
0.2191th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

419 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic1
VUS268
Likely Benign105
Benign14
Conflicting28
1
Pathogenic
1
Likely Pathogenic
268
VUS
105
Likely Benign
14
Benign
28
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
0
0
1
Likely Pathogenic
1
0
0
0
1
VUS
30
222
14
2
268
Likely Benign
0
6
34
65
105
Benign
0
3
8
3
14
Conflicting
28
Total312325670417

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

102 pathogenic / likely-pathogenic (of 112) ClinVar copy-number / structural variants overlap SLC10A2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC10A2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →